Interestingly, the 1-D-MT-mediated upregulation of IDO1 mRNA in many IDO1-negative cancer cells was differentially dependent of the concentration of IFN-γ that was used to induce de novo expression of IDO1 (Fig. 6C). The gene discussed is IDO1; the disease is cancer.